Mariia S Larkina

13PUBLICATIONS
43CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical molecular engineering of nucleic acids and proteinsCancer diagnosisPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Mar 30, 2026
Cardioprotection in oncology: Mechanisms, risks and therapeutic strategies.

E Plotnikov, V Chernov, R Zelchan

|Mar 04, 2026
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

Sergey Deyev, Anastasia Fominykh, Ruslan Varvashenya

|Jan 28, 2026
Evaluation of the Functional Suitability of Carboxylate Chlorin e6 Derivatives for Use in Radionuclide Diagnostics.

Mariia Larkina, Anastasia Demina, Nikita Suvorov

|Nov 13, 2025
Comparative Preclinical Evaluation of the Tumor-Targeting Properties of Radioiodine and Technetium-Labeled Designed Ankyrin Repeat Proteins for Imaging of Epidermal Growth Factor Receptor Expression in Malignant Tumors.

Mariia Larkina, Gleb Yanovich, Lutfi Aditya Hasnowo

|Oct 29, 2025
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?

Anna Orlova, Anastasia Rybina, Anna Medvedeva

|Aug 28, 2025
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8.

Olga Bragina, Vladimir Chernov, Mariia Larkina

Pageof 3

Frequent Collaborators

8 joint publications

Anna Orlova

7 joint publications

Vladimir Tolmachev

4 joint publications

Evgenii Plotnikov

4 joint publications

Anzhelika Vorobyeva